Latest news with #WorldImmunizationWeek
Qatar Tribune
07-05-2025
- Health
- Qatar Tribune
MoPH continues efforts to improve vaccine access across Qatar
DOHA: The Ministry of Public Health (MoPH) has announced that the number of vaccines included in Qatar's national immunization schedule has risen to 15, contributing to the prevention of 17 diseases and their complications. An MoPH statement said the vaccines, available free of charge in all Hamad Medical Corporation's primary healthcare centers as well as in 70 private centers, cover all groups within society, including children, adolescents, adults, the elderly, pregnant women, travelers, people with chronic conditions, and healthcare workers. Several vaccines have also been approved and added in recent years, including the human papillomavirus (HPV) vaccine for adolescents, the shingles (herpes zoster) vaccine, and the respiratory syncytial virus (RSV) vaccine for the elderly. The statement added that MoPH is working with technical support from the National Immunization Technical Advisory Group, to monitor and ensure the safety of vaccines. The MoPH has intensified its awareness efforts on the occasion of World Immunization Week, which is designated by the World Health Organization during the last week of April each year. This year's celebration is held under the theme "Humanly Possible: Immunization for All," and the week represents an opportunity to enhance access to and use of vaccines to protect individuals and communities from diseases and epidemics. The efforts to improve vaccine access in the State of Qatar are being made in cooperation with its partners in the healthcare sector, with the ministry calling on members of the public and its partners to play a vital role in protecting themselves and their loved ones from diseases by supporting and improving access to vaccines.
Canada Standard
01-05-2025
- Health
- Canada Standard
From COVID to cancer: Why Canada's RNA vaccine leadership matters more than ever
As the world marks World Immunization Week, attention turns once again to the lifesaving power of vaccines. Amid headlines about rising cases of measles, falling vaccination rates and growing vaccine hesitancy, a quieter revolution is underway - one that could fundamentally reshape how we respond to global health threats, including pandemics and cancer. This revolution is being powered by RNA technology - and Canada is uniquely positioned to lead it. While the swift development of COVID-19 vaccines appeared to be a sudden scientific triumph, it was built on six decades of foundational work. Much of that work happened in Canada. Messenger RNA (mRNA) are large, negatively charged molecules that are easily degraded and repelled by our cells. To coax our cells to internalize them, scientists developed a way to encapsulate them in "fat bubbles" or lipid nanoparticles (LNPs), which were invented by Pieter Cullis and collaborators. Cullis, a co-author of this article, is a professor in biochemistry and molecular biology at the University of British Columbia. Once inside a patients' cells, the mRNA gives the cell instructions to translate a viral protein that triggers an immune response. Both the Pfizer/BioNTech and Moderna vaccines - which relied on these fat bubbles - were found to be highly efficacious (more than 94 per cent) and safe, both in initial trials and continuous monitoring over time. They were estimated to have saved nearly 10 million lives in 2021 alone. That's just the beginning. Research teams across the country are now building on this homegrown innovation to expand the potential of RNA vaccines beyond infectious diseases. At the University of British Columbia, the Blakney Lab is focused on developing vaccines and therapies using self-amplifying RNA (saRNA), a technology that offers several advantages over conventional mRNA. Because saRNA replicates itself once inside a patient's cells, much smaller doses are needed to produce a robust immune response. Now, this replication process may sound like something out of a science fiction film, but similar to mRNA vaccines, this technology has been developed over decades and has been thoroughly clinically validated. The saRNA technology reduces manufacturing costs and makes vaccine production more scalable during global emergencies. Notably, the lower dose can also minimize side effects, potentially reducing the risk of getting a sore arm or having to miss a day of work after vaccination. Recent pre-clinical studies have shown that saRNA vaccines can offer longer-lasting immunity with smaller doses, and multiple clinical trials are now underway to evaluate their use for influenza, Zika virus and even cancer. Expanding Canada's domestic RNA vaccine capacity is more than just a scientific priority; it's a public health imperative and economic opportunity. During the COVID-19 pandemic, global supply chain breakdowns exposed the risks of relying on international sources for essential vaccine ingredients and production. Investing in local infrastructure allows for faster and more flexible responses to future outbreaks. Read more: From PPE shortages to COVID-19 vaccine distribution, the supply chain has emerged as a determinant of health But it's not just about pandemic readiness. One of the most exciting frontiers for RNA technology is the development of personalized cancer vaccines. These vaccines train the immune system to recognize and attack mutations specific to an individual's tumour. In early clinical trials, mRNA-based cancer vaccines - such as those developed by Moderna and BioNTech - have shown promising results, dramatically reducing recurrence rates in melanoma and pancreatic cancer patients. Canada's scientific ecosystem is primed to contribute meaningfully to this next generation of therapies. Strengthening our biotech infrastructure could create high-quality jobs, stimulate economic growth and reinforce Canada's place as a leader in the global bioeconomy. The COVID-19 pandemic showed us how rapidly science can enable positive public health outcomes - and how easily inequities can widen if infrastructure and access aren't prioritized. Despite being home to world-class researchers, Canada lacked the manufacturing capacity to produce its own mRNA vaccines. That gap is now being addressed through substantial recent investments from the government of Canada, but sustaining momentum will require long-term commitment from policymakers and funders. Equity must also remain at the forefront. Communities in rural, remote and Indigenous regions often face barriers to accessing vaccines - not because of hesitancy, but due to logistical challenges and under-resourced health systems. The Public Health Agency of Canada has emphasized the importance of building trust and tailoring solutions in partnership with these communities. Vaccine confidence remains another challenge. Post-pandemic surveys reveal that misinformation continues to shape public perceptions, even about long-established vaccines like MMR. Addressing this requires proactive science communication, sustained public education and rebuilding trusted relationships between communities and health systems. World Immunization Week offered a chance to celebrate how far we've come - but also to ask what comes next. With decades of research leadership, a strong innovation ecosystem and new investments in RNA infrastructure, Canada has the tools to lead the next chapter of mRNA technology development. Whether it's fighting the next virus or personalizing cancer therapies for individual patients, RNA technologies hold transformative promise. Seizing this opportunity will require sustained support, policy alignment and a focus on equitable access. By investing in RNA innovation today, Canada can deliver not just vaccines, but a healthier, more resilient future for all. Immunity and Society is a new series from The Conversation Canada that presents new vaccine discoveries and immune-based innovations that are changing how we understand and protect human health. Through a partnership with the Bridge Research Consortium, these articles - written by academics in Canada at the forefront of immunology and biomanufacturing - explore the latest developments and their social impacts.
Pembrokeshire Herald
29-04-2025
- Health
- Pembrokeshire Herald
Measles and mumps return: Vaccine warnings reignite public anger
A WARNING from Hywel Dda Health Board that measles and mumps are resurging in Wales has exposed deep divisions over vaccines, sparking an explosive reaction online. In a statement released during World Immunization Week, the health board urged parents to ensure their children receive the MMR (measles, mumps, rubella) vaccine, describing it as the 'best protection' against life-threatening complications such as meningitis, deafness, and even death. 'If 95% of children receive the MMR vaccine, measles could be wiped out completely,' the health board said. 'However, outbreaks occur when vaccination rates drop below 90%.' The reminder prompted hundreds of responses online, quickly descending into a battle between public health advocates and vaccine sceptics. One mother, Rachel Beckett, shared a harrowing memory of suffering from mumps as a child: 'I remember lying in agony on my mother's bed while the sound of kids playing outside echoed in. I thought I was dying.' Other commenters warned that many younger parents do not realise the dangers because vaccines have made serious complications rare in modern Britain. 'Vaccines made these horrors a distant memory,' said one user. However, vaccine sceptics questioned the motivations behind immunisation campaigns. Some suggested doctors receive financial incentives for administering vaccines. Official NHS documents show GP practices are paid a fee per jab administered, around £10, to cover service delivery – but health professionals point out that the payments fund surgery costs, not individual bonuses. 'GPs are not profiting personally from vaccinations,' wrote one commentator. 'The payments are for providing services, not backhanders.' The controversy also reignited the long-running debate over Andrew Wakefield's discredited claims linking the MMR vaccine to autism. Although his research was found to be fraudulent and his medical licence revoked, misinformation continues to circulate. Public health advocates were blunt in response. Gareth Pitt-Nash wrote: 'Just google 'Lancet MMR fraud'. It's not a mystery why measles is coming back when people ignore science.' Others warned that falling vaccination rates could result in a return to the dark days when measles, rubella, and mumps caused widespread childhood disability and death. As of 2025, UK childhood vaccination rates for MMR remain below the World Health Organization's recommended target of 95%, leaving communities vulnerable to outbreaks. The health board urged families to check their vaccination records urgently, stating that catching up with missed vaccines could save lives. The facts about the MMR vaccine What is the MMR vaccine? The MMR vaccine protects against three serious diseases: measles, mumps, and rubella (German measles). How effective is it? Two doses of the MMR vaccine provide about 99% protection against measles, 88% protection against mumps, and 97% protection against rubella. When is it given? Children are usually given their first dose at 12–13 months old, and a second dose at around 3 years and 4 months, before starting school. Is it safe? The MMR vaccine has been used safely for over 30 years. Millions of doses are given worldwide every year. Serious side effects are extremely rare. Mild side effects such as a sore arm or mild fever are common and temporary. Why is high uptake important? At least 95% of children need to be vaccinated to prevent outbreaks. If vaccination rates fall below 90%, diseases like measles can spread rapidly again. What about the autism claim? A study published in 1998 suggested a link between MMR and autism. This study was found to be fraudulent, was retracted, and the author was struck off the medical register. Extensive research since has found no link between the MMR vaccine and autism. What are the risks of measles, mumps, and rubella? Measles can cause meningitis, pneumonia, blindness, and death. Mumps can cause deafness and swelling of the brain. Rubella can cause serious birth defects if a pregnant woman catches it. Where to find more information: Visit Public Health Wales – MMR vaccine. Readers react: Vaccines, health risks, and mistrust A simple public health warning about rising measles and mumps cases ignited a fierce debate among local residents. Some shared harrowing personal experiences: 'My daughter was like a rag doll for a week with measles. It was terrifying.' – Pat Greenhorn 'I had mumps so badly I couldn't swallow without pain at three years old. Don't put children through that.' – Rachel Beckett Others defended vaccinations: 'Vaccines made these diseases rare. Now misinformation is undoing that progress.' – Jacqueline White 'Measles killed children. Rubella caused birth defects. Vaccines are not optional.' – Diana Salmon However, some questioned the motives behind vaccine campaigns: 'GP practices get paid per vaccine given. It's about money, not health.' – Melissa Jade 'Big pharma profits more from sick people than healthy ones.' – Cantalope Catalina And others called for calm: 'GPs don't pocket bonuses. Payments fund services, not personal profits.' – Katy Hocking The underlying message from health professionals remains simple: without high vaccination rates, once-defeated diseases will return.
Pembrokeshire Herald
29-04-2025
- Health
- Pembrokeshire Herald
Pembrokeshire County Council: Two senior members step down
A WARNING from Hywel Dda Health Board that measles and mumps are resurging in Wales has exposed deep divisions over vaccines, sparking an explosive reaction online. In a statement released during World Immunization Week, the health board urged parents to ensure their children receive the MMR (measles, mumps, rubella) vaccine, describing it as the 'best protection' against life-threatening complications such as meningitis, deafness, and even death. 'If 95% of children receive the MMR vaccine, measles could be wiped out completely,' the health board said. 'However, outbreaks occur when vaccination rates drop below 90%.' The reminder prompted hundreds of responses online, quickly descending into a battle between public health advocates and vaccine sceptics. One mother, Rachel Beckett, shared a harrowing memory of suffering from mumps as a child: 'I remember lying in agony on my mother's bed while the sound of kids playing outside echoed in. I thought I was dying.' Other commenters warned that many younger parents do not realise the dangers because vaccines have made serious complications rare in modern Britain. 'Vaccines made these horrors a distant memory,' said one user. However, vaccine sceptics questioned the motivations behind immunisation campaigns. Some suggested doctors receive financial incentives for administering vaccines. Official NHS documents show GP practices are paid a fee per jab administered, around £10, to cover service delivery – but health professionals point out that the payments fund surgery costs, not individual bonuses. 'GPs are not profiting personally from vaccinations,' wrote one commentator. 'The payments are for providing services, not backhanders.' The controversy also reignited the long-running debate over Andrew Wakefield's discredited claims linking the MMR vaccine to autism. Although his research was found to be fraudulent and his medical licence revoked, misinformation continues to circulate. Public health advocates were blunt in response. Gareth Pitt-Nash wrote: 'Just google 'Lancet MMR fraud'. It's not a mystery why measles is coming back when people ignore science.' Others warned that falling vaccination rates could result in a return to the dark days when measles, rubella, and mumps caused widespread childhood disability and death. As of 2025, UK childhood vaccination rates for MMR remain below the World Health Organization's recommended target of 95%, leaving communities vulnerable to outbreaks. The health board urged families to check their vaccination records urgently, stating that catching up with missed vaccines could save lives. The facts about the MMR vaccine What is the MMR vaccine? The MMR vaccine protects against three serious diseases: measles, mumps, and rubella (German measles). How effective is it? Two doses of the MMR vaccine provide about 99% protection against measles, 88% protection against mumps, and 97% protection against rubella. When is it given? Children are usually given their first dose at 12–13 months old, and a second dose at around 3 years and 4 months, before starting school. Is it safe? The MMR vaccine has been used safely for over 30 years. Millions of doses are given worldwide every year. Serious side effects are extremely rare. Mild side effects such as a sore arm or mild fever are common and temporary. Why is high uptake important? At least 95% of children need to be vaccinated to prevent outbreaks. If vaccination rates fall below 90%, diseases like measles can spread rapidly again. What about the autism claim? A study published in 1998 suggested a link between MMR and autism. This study was found to be fraudulent, was retracted, and the author was struck off the medical register. Extensive research since has found no link between the MMR vaccine and autism. What are the risks of measles, mumps, and rubella? Measles can cause meningitis, pneumonia, blindness, and death. Mumps can cause deafness and swelling of the brain. Rubella can cause serious birth defects if a pregnant woman catches it. Where to find more information: Visit Public Health Wales – MMR vaccine. Readers react: Vaccines, health risks, and mistrust A simple public health warning about rising measles and mumps cases ignited a fierce debate among local residents. Some shared harrowing personal experiences: 'My daughter was like a rag doll for a week with measles. It was terrifying.' – Pat Greenhorn 'I had mumps so badly I couldn't swallow without pain at three years old. Don't put children through that.' – Rachel Beckett Others defended vaccinations: 'Vaccines made these diseases rare. Now misinformation is undoing that progress.' – Jacqueline White 'Measles killed children. Rubella caused birth defects. Vaccines are not optional.' – Diana Salmon However, some questioned the motives behind vaccine campaigns: 'GP practices get paid per vaccine given. It's about money, not health.' – Melissa Jade 'Big pharma profits more from sick people than healthy ones.' – Cantalope Catalina And others called for calm: 'GPs don't pocket bonuses. Payments fund services, not personal profits.' – Katy Hocking The underlying message from health professionals remains simple: without high vaccination rates, once-defeated diseases will return.
The Hindu
29-04-2025
- Health
- The Hindu
Letters to The Editor — April 30, 2025
Continue immunisation The warning sounded by the World Health Organization, UNICEF and Gavi (the Vaccine Alliance), in the context of World Immunization Week, April 24-30, of 'increases in vaccine-preventable disease outbreaks threatening years of progress', is one that should not be ignored under any circumstances. Neglecting this could be catastrophic for the world. All children and adults (especially women) should be immunised according to the latest national immunisation schedule sanctioned by the Ministry of Health & Family Welfare and ICMR. The Government of India must ensure that there is no slowing down of immunisation coverage. Dr. Sunil Chopra, Ludhiana, Punjab Stray dog issue As an octogenarian veterinarian, I have been keenly following the narratives on the stray dog problem. Unfortunately, implementation of vaccination and sterilisation has not been as robust as it should have been, with concerns about inadequate outreach and sterilisation rates. A significant proportion of dogs remain reproductively active. As human health and life are important, this is an issue that has to be tackled through a more stringent and practical approach. Dog shelters can be set up in each corporation zone, roping in even corporates under Corporate Social Responsibility (CSR) initiatives. In many countries even pets are not allowed loose on a street. Dr. T.N. Varadarajan, Chennai Shaji N. Karun Shaji N. Karun, one among the pantheon of great film-makers, has become a glowing chapter in Kerala's rich film history. As a director and cinematographer, he excelled in both worlds. With his classic films such as Swaham, Piravi and Vanaprastham, he made an indelible mark in world cinema. And, while at the Kerala State Chalachithra Academy and Kerala State Film Development Corporation, he proved to be an institution builder. Ayyasseri Raveendranath, Aranmula, Kerala
